Screener
Sarepta Therapeutics, Inc. SRPT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s enterprise value?
- Sarepta Therapeutics, Inc. (SRPT) reported enterprise value of $1.52B in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s enterprise value changed year-over-year?
- Sarepta Therapeutics, Inc.'s enterprise value decreased by 2.9% year-over-year, from $1.57B to $1.52B.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s enterprise value has grown at a -32.8% compound annual growth rate (CAGR), from $12.14B to $1.66B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Sarepta Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude